Treatment with High Dose [¹¹¹In-DTPA-D-PHE¹]-Octreotide in Patients with Neuroendocrine Tumors: Evaluation of Therapeutic and Toxic Effects

REFERENCES

• Virgolini I, Pangerl T, Bischof C, Smith-Jones P, Peck-Ra-dosavljevic M. Somatostatin receptor subtype expression in human tissues: a prediction for diagnosis and treatment of cancer? Eur J Clin Invest 1997; 27: 645–7.
   Google Scholar
• Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gas-trointestinal tract, and kidney. Proc Natl Acad Sci 1992; 89: 251–5.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Reisine T, Law SF, et al. Somatostatin receptors, an expanding gene family: cloning and functional characteri-zation of human SSTR3, a protein coupled to adenylyl cy-clase. Mol Endocrinol 1992; 6: 2136–42.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Kagimoto S, Kubota A, et al. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun 1993; 195: 844–52.
   PubMed Web of Science ®Google Scholar
• Reubi JC, Kvols LK, Waser B, et al. Detection of somato-statin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990; 50: 5969–77.
   PubMed Web of Science ®Google Scholar
• Janson ET, Gobl A, Kälkner KM, Öberg K. A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients. Cancer Res 1996; 56: 2561–5.
   Google Scholar
• Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somato-statin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr]octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716–31.
   PubMedGoogle Scholar
• Reichlin, S. Somatostatin I and II. N Engl J Med 1983; 309: 1495-501, 1556–63.
   PubMedGoogle Scholar
• Bauer W, Briner U, Doepfner W, et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sciences 1982; 31: 1133–40.
   PubMed Web of Science ®Google Scholar
• Lamberts SWJ, van der Lely AJ, de Herder WW, Hofland LJ, et al. Octreotide. N Engl J Med 1996; 334: 246–54.
   PubMed Web of Science ®Google Scholar
• Westlin JE, Janson ET, Ahlström H, öberg K, Nilsson S. Somatostatin receptor scintigraphy of carcinoid tumours us-ing the [111In-DTPA-D-Phe1]—octreotide. Acta Oncol 1993; 32: 783–6.
   Google Scholar
• Janson ET, Westlin JE, Eriksson B, Ahlström H, Nilsson S, öberg K. 111In-DTPA-D-Phe1Foctreotide scintigraphy in pa-tients with carcinoid tumors: the predictive value for somato-statin analogue treatment. Eur J Endocrinol 1994; 131: 577–81.
   Google Scholar
• öhrvall U, Westlin JE, Nilsson S, et al. Human biodistribu-tion of [111In]diethylenetriaminepentaacetic acid (DTPA)-D-[Phel]-octreotide and preoperative detection of endocrine tumors. Cancer Res 1995; 55: 5794–800.
   Google Scholar
• Krenning EP, Kooij PPM, Pauwels S, et al. Somatostatin receptor: scintigraphy and radionuclide therapy. Digestion 1996; 57 (Suppl 1): 57–61.
   PubMed Web of Science ®Google Scholar
• McCarthy KE, Woltering EA, Espenan GD, Cronin M, Maloney TJ, Anthony LB. In situ radiotherapy with 111In-pentetreotide: initial observations and future directions. Can-cer J Sci Am 1998; 4: 94–102.
   PubMedGoogle Scholar
• Westlin JE, Janson ET, Ahlström H, Nilsson S, öhrvall U, Öberg K. Scintigraphy using a 111-indium4abeled somato-statin analogue for localization of neuroendocrine tumors. Antibody Immunocon Radiopharm 1992; 20: 367–84.
   Google Scholar
• Kaminski MS, Zasadny KR, Francis IR, et al. Radioim-munotherapy of B-cell lymphoma with [1311]-anti-B1 (anti-CD20) antibody. N Engl J Med 1993; 329: 459–65.
   PubMed Web of Science ®Google Scholar
• Press OW, Eary JF, Appelbaum FR, et al. Phase II trial of 1311-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B-cell lymphomas. Lancet 1995; 346: 336–40.
   PubMed Web of Science ®Google Scholar
• Hoefnagel CA. Radionuclide therapy revisited. Eur J Nucl Med 1991; 18: 408–31.
   PubMedGoogle Scholar
• McLean JR, Blakey DH, Douglas GR, Bayley J. The Auger electron dosimetry of indium-111 in mammalian cells in vitro. Radiat Res 1989; 119: 205–18.
   PubMed Web of Science ®Google Scholar
• Hukovic N, Panetta R, Kumar U, Patel YC. Agonist-depen-dent regulation of cloned human somatostatin receptor types 1-5 (hSSTR 1-5): subtype selective internalization or upregu-lation. Endocrinology 1996; 137: 4046–9.
   PubMed Web of Science ®Google Scholar
• Otte A, Mueller-Brand J, Dellas S, Nitzsche EU, Herrmann R, Maecke HR. Yttrium-90-labelled somatostatin analogue for cancer treatment. Lancet 1998; 351: 417–8.
   PubMed Web of Science ®Google Scholar